2026 NPPES data Nurse Practitioner NPI 1215318555 CNP
Verify on CMS →

Roseviminda Abano, CNP

Nurse Practitioner in Gurnee, Illinois.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 89,808 in Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 258 beneficiaries · Nurse Practitioner avg: 1K
Generic prescribing
87%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$37.67
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Roseviminda Abano, CNP filed 1,265 Medicare Part D claims in 2024 as a Nurse Practitioner in Gurnee, Illinois, prescribing 87% generic.

1K
Part D claims, 2024
87%
generic prescribing
$37.67
industry payments (Sunshine Act)
≥78th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Roseviminda Abano, CNP

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1215318555), first enumerated 06/12/2015.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,265 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Industry payment transparency

    $37.67 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Illinois statewide board action statistics are published annually — these figures describe aggregate state activity, not Roseviminda Abano, CNP's individual license status. Verify directly with the state medical board.

    Source: IDFPR annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1215318555 · Nurse Practitioner

NPI-10 · ENUM-MID · TAX-MEGA · RX-MID · BOOK-LIGHT · PHOTO-ENUM

  • NPI-10 1215318555
  • ENUM-MID 2015
  • TAX-MEGA 90K Nurse Practitioner
  • RX-MID 1,265
  • BOOK-LIGHT 4,005 in Illinois
  • PHOTO-ENUM Jeff Knoll · 2015

Roseviminda Abano, CNP's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

1,265 ≥ 78th percentile 78% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). Below this entry. 1,000–1,200: 33,612 prescribers (2%). Below this entry. 1,200–1,400: 27,889 prescribers (2%). This entry sits in this band. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

What does the federal data show about Roseviminda Abano, CNP?

Quality data not reported

NPI registry status

Active

Issued 06/12/2015

NPI 1215318555

Primary specialty

Nurse Practitioner

High-volume

89,808 US NPIs in this specialty

Medicare Part D claims

1,265 11% vs specialty avg

2024 prescription claims

Specialty avg: 1,144

Specialty distribution in Illinois

How Nurse Practitioner compares to other specialties among Illinois providers

Illinois providers
Clinical Social Worker5.2%Physical Therapist4.9%Mental Health Counselor4.5%Speech-Language Pathologist4.2%Student in an Organized Heal…4.1%Pharmacist4.1%Nurse Practitioner1.7%
Largest specialties in Illinois (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Nurse Practitioner. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

7501 GRAND AVE
Gurnee, IL 60031

Provider Details

NPI 1215318555
Specialty Nurse Practitioner
Credentials CNP
Gender Female
NPI Issued 06/12/2015

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Roseviminda Abano, CNP. Source: openpaymentsdata.cms.gov.

Total received

$38

Largest payer

Otsuka America Pharmaceutical, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Illinois IDFPR 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Roseviminda Abano, CNP. To verify Roseviminda Abano, CNP's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Roseviminda Abano, CNP - brand share 11.0%
Nurse Practitioner average

11% brand-name claims vs 87% generic, on 1,265 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,265
Total Claims
$90K
Total Drug Cost
258
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,420.033
Total Day Supply
67,049
Brand vs Generic
11% brand / 87% generic
Brand Drug Cost
$66K
Generic Drug Cost
$24K
Opioid Claims
31 (2.5% rate)
Antibiotic Claims
95

Patient Demographics

Average Patient Age
75.5 years
Avg HCC Risk Score
1.56
Gender Split
52% female / 48% male
Age Distribution
<65: 23, 65-74: 96, 75-84: 101, 85+: 38

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Roseviminda Abano, CNP prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Levothyroxine Sodium
58
Amlodipine Besylate
45
Pantoprazole Sodium
40
Metformin Hcl
39
Omeprazole
39
Simvastatin
36
Atorvastatin Calcium
35
Lisinopril
34
Furosemide
31
Tamsulosin Hcl
29

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nurse Practitioner Overview

How Roseviminda Abano, CNP fits within the Nurse Practitioner landscape nationally.

89,808
Nurse Practitioner Providers in US
56
States with Nurse Practitioner
1,144
Avg Claims per Provider

Roseviminda Abano, CNP's 1,265 claims are above the specialty average of 1,144.

Nationwide Nurse Practitioner peers with similar MIPS or enrollment year

Two federal-record peer sets for Abano, both outside Illinois so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2015)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Nurse Practitioner Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Abano.

One of 4,005 Nurse Practitioner providers enrolled in Illinois, 5 are shown here.

Compare Nurse Practitioner nationally: see state-by-state distribution →

Frequently Asked Questions

What is Roseviminda Abano, CNP's specialty?
Roseviminda Abano, CNP specializes in Nurse Practitioner and practices in Gurnee, Illinois. Credentials: CNP.
How much does Roseviminda Abano, CNP prescribe under Medicare Part D?
In 2024, Roseviminda Abano, CNP wrote 1,265 Medicare Part D claims totaling $90K in drug costs for 258 beneficiaries.
Where is Roseviminda Abano, CNP located?
Roseviminda Abano, CNP is located at 7501 GRAND AVE, Gurnee, IL, 60031. Phone: (800) 323-8622.
What is Roseviminda Abano, CNP's NPI number?
Roseviminda Abano, CNP's National Provider Identifier (NPI) is 1215318555, issued on 06/12/2015.
Does Roseviminda Abano, CNP prescribe more brand-name or generic drugs?
Roseviminda Abano, CNP's prescribing is 11% brand-name and 87% generic drugs by claim count, with $66K in brand drug costs.
Does Roseviminda Abano, CNP prescribe opioids?
Yes, Roseviminda Abano, CNP had 31 opioid claims in 2024 with an opioid prescribing rate of 2.5%.
How many Nurse Practitioner providers are there in the US?
There are 89,808 Nurse Practitioner providers across 56 states in the US. The average Nurse Practitioner provider writes 1,144 Medicare Part D claims per year.
What drugs does Roseviminda Abano, CNP prescribe most often?
Based on 2024 Medicare Part D data, Roseviminda Abano, CNP's most frequently prescribed drugs include Levothyroxine Sodium, Amlodipine Besylate, Pantoprazole Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Roseviminda Abano, CNP accept Medicare?
Roseviminda Abano, CNP appears in CMS Medicare data with 1,265 Part D claims and 258 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Roseviminda Abano, CNP's credentials?
Roseviminda Abano, CNP's NPI is 1215318555 with credentials CNP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.